TY - JOUR
T1 - Proteomic analysis of necroptotic extracellular vesicles
AU - Shlomovitz, Inbar
AU - Erlich, Ziv
AU - Arad, Gali
AU - Edry-Botzer, Liat
AU - Zargarian, Sefi
AU - Cohen, Hadar
AU - Manko, Tal
AU - Ofir-Birin, Yifat
AU - Cooks, Tomer
AU - Regev-Rudzki, Neta
AU - Gerlic, Motti
N1 - Funding Information:
This work was performed in partial fulfilment of the requirements for a PhD degree (I.S., G.A., Z.E., S.Z. and H.C.), Sackler Faculty of Medicine, Tel Aviv University, Israel. We thank The Smoler Proteomics Center at the Technion for performing the mass spectrometry. We would also like to thank Dr. Mary Speir for editing this manuscript. This work was supported by the Recanati Foundation (TAU), received by M.G.; Israel Science Foundation (ISF) under Grants #1416/15 and 818/18, received by M.G.; Alpha-1 foundation under Grant #615533, received by M.G.; U.S.–Israel Binational Science Foundation (BSF) under Grant #2017176, received by M.G.; Individual research grant from Varda and Boaz Dotal Research Center in Hemato-Oncology, received by M.G.; Israel Science Foundation (ISF) under Grant #2235/16, received by N.R.R., and Enid Barden and Aaron J. Jade President’s Development Chair for New Scientists in Memory of Cantor John Y. Jade, received by N.R.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of paper.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Necroptosis is a regulated and inflammatory form of cell death. We, and others, have previously reported that necroptotic cells release extracellular vesicles (EVs). We have found that necroptotic EVs are loaded with proteins, including the phosphorylated form of the key necroptosis-executing factor, mixed lineage kinase domain-like kinase (MLKL). However, neither the exact protein composition, nor the impact, of necroptotic EVs have been delineated. To characterize their content, EVs from necroptotic and untreated U937 cells were isolated and analyzed by mass spectrometry-based proteomics. A total of 3337 proteins were identified, sharing a high degree of similarity with exosome proteome databases, and clearly distinguishing necroptotic and control EVs. A total of 352 proteins were significantly upregulated in the necroptotic EVs. Among these were MLKL and caspase-8, as validated by immunoblot. Components of the ESCRTIII machinery and inflammatory signaling were also upregulated in the necroptotic EVs, as well as currently unreported components of vesicle formation and transport, and necroptotic signaling pathways. Moreover, we found that necroptotic EVs can be phagocytosed by macrophages to modulate cytokine and chemokine secretion. Finally, we uncovered that necroptotic EVs contain tumor neoantigens, and are enriched with components of antigen processing and presentation. In summary, our study reveals a new layer of regulation during the early stage of necroptosis, mediated by the secretion of specific EVs that influences the microenvironment and may instigate innate and adaptive immune responses. This study sheds light on new potential players in necroptotic signaling and its related EVs, and uncovers the functional tasks accomplished by the cargo of these necroptotic EVs.
AB - Necroptosis is a regulated and inflammatory form of cell death. We, and others, have previously reported that necroptotic cells release extracellular vesicles (EVs). We have found that necroptotic EVs are loaded with proteins, including the phosphorylated form of the key necroptosis-executing factor, mixed lineage kinase domain-like kinase (MLKL). However, neither the exact protein composition, nor the impact, of necroptotic EVs have been delineated. To characterize their content, EVs from necroptotic and untreated U937 cells were isolated and analyzed by mass spectrometry-based proteomics. A total of 3337 proteins were identified, sharing a high degree of similarity with exosome proteome databases, and clearly distinguishing necroptotic and control EVs. A total of 352 proteins were significantly upregulated in the necroptotic EVs. Among these were MLKL and caspase-8, as validated by immunoblot. Components of the ESCRTIII machinery and inflammatory signaling were also upregulated in the necroptotic EVs, as well as currently unreported components of vesicle formation and transport, and necroptotic signaling pathways. Moreover, we found that necroptotic EVs can be phagocytosed by macrophages to modulate cytokine and chemokine secretion. Finally, we uncovered that necroptotic EVs contain tumor neoantigens, and are enriched with components of antigen processing and presentation. In summary, our study reveals a new layer of regulation during the early stage of necroptosis, mediated by the secretion of specific EVs that influences the microenvironment and may instigate innate and adaptive immune responses. This study sheds light on new potential players in necroptotic signaling and its related EVs, and uncovers the functional tasks accomplished by the cargo of these necroptotic EVs.
UR - http://www.scopus.com/inward/record.url?scp=85118672476&partnerID=8YFLogxK
U2 - 10.1038/s41419-021-04317-z
DO - 10.1038/s41419-021-04317-z
M3 - Article
C2 - 34750357
AN - SCOPUS:85118672476
VL - 12
JO - Cell Death and Disease
JF - Cell Death and Disease
SN - 2041-4889
IS - 11
M1 - 1059
ER -